Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study.
Oh E, Cheon SM, Cho JW, Sung YH, Kim JS, Shin HW, Kim JM, Park MY, Kwon DY, Ma H 2nd, Park JH, Koh SB, Choi SM, Park J, Lee PH, Ahn TB, Kim SJ, Lyoo CH, Lee HW, Kim J, Lee Y, Baik JS.
Oh E, et al. Among authors: cho jw.
J Neural Transm (Vienna). 2024 Nov 14. doi: 10.1007/s00702-024-02851-6. Online ahead of print.
J Neural Transm (Vienna). 2024.
PMID: 39540934